British drugs firm GSK settles US drug disputes for $3.0 bln
Thursday, November 3, 2011 - 08:00
in Mathematics & Economics
GlaxoSmithKline said on Thursday it had agreed to pay $3.0 billion (2.2 billion euros) to settle long-running disputes with the US government over how the British pharmaceuticals group marketed and developed drugs.